Precision BioSciences amends bylaws for universal proxy and nomination procedures

PRECISION BIOSCIENCES INC

Board adopted amended bylaws on Dec 19, 2023, effective same day, addressing SEC universal proxy rules.
New rules require compliance with Rule 14a-19 for proxy solicitations supporting non-Board nominees.
Enhanced disclosure requirements for stockholder nominations and proposals, including derivative interests.
Prohibits stockholders from submitting more director nominees than seats up for election.
Requires proxy cards for dissident solicitations to be a color other than white.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

PRECISION BIOSCIENCES INC: Amended and restated bylaws to address universal proxy rules, update stockholder nomination and proposal procedures, and make technical changes (effective 2023-12-19).

Change: bylaw amendment
Effective: 2023-12-19

Exact text from the filing

On December 19, 2023, the Board of Directors (the “Board”) of Precision BioSciences, Inc. (the “Company”) approved and adopted amendments to the Company’s amended and restated bylaws (as amended, the “Amended and Restated Bylaws”), which became effective the same day.

View on SEC.gov

247 governance changes filed in the last 30 days. Browse all governance changes →

PRECISION BIOSCIENCES INC filing history →

Source: SEC EDGAR

accession 0000950170-23-072457

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.